Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatment
Cancer Reports · 2024
DOI: 10.1002/cnr2.2009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2024. Verfasst von Most Shornale Akter und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Genetic Engineering, Islamic University, Kushtia, Bangladesh. Hauptthemen laut MEDLINE: Breast Neoplasms, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Gene Expression Profiling. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast cancer (BC) is the most widespread cancer worldwide. Over 2 million new cases of BC were identified in 2020 alone. Despite previous studies, the lack of specific biomarkers and signaling pathways implicated in BC impedes the development of potential therapeutic strategies. We employed several RNAseq datasets to extract differentially expressed genes (DEGs) based on the intersection of all datasets, followed by protein–protein interaction network construction. Using the shared DEGs, we also identified significant gene ontology (GO) and KEGG pathways to understand the signaling pathways involved in BC development. A molecular docking simulation was performed to explore potential interactions between proteins and drugs. The intersection of the four datasets resulted in 146 DEGs common, including AURKB, PLK1, TTK, UBE2C, CDCA8, KIF15, and CDC45 that are significant hub‐proteins associated with breastcancer development. These genes are crucial in complement activation, mitotic cytokinesis, aging, and cancer development. We identified key microRNAs (i.e., hsa‐miR‐16‐5p, hsa‐miR‐1‐3p, hsa‐miR‐147a, hsa‐miR‐195‐5p, and hsa‐miR‐155‐5p) that are associated with aggressive tumor behavior and poor clinical outcomes in BC. Notable transcription factors (TFs) were FOXC1, GATA2, FOXL1, ZNF24 and NR2F6. These biomarkers are involved in regulating cancer cell proliferation, invasion, and migration. Finally, molecular docking suggested Hesperidin, 2‐amino‐isoxazolopyridines, and NMS‐P715 as potential lead compounds against BC progression. We believe that these findings will provide important insight into the BC progression as well as potential biomarkers and drug candidates for therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology and Genetic Engineering, Islamic University, Kushtia, Bangladesh.
- Department of Biotechnology and Genetic Engineering, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh.
- Department of Microbiology, Primeasia University, Dhaka, Bangladesh.
- Department of Statistics, Jagannath University, Dhaka, Bangladesh.
- Department of Computer Science and Engineering, Islamic University, Kushtia, Bangladesh.
- Center for Advanced Bioinformatics and Artificial Intelligence Research, Islamic University, Kushtia, Bangladesh.
ORCID-Profile: Md Habibur Rahman
Zitieren
APA
Shornale Akter, M., Uddin, M. H., Atikur Rahman, S., Hossain, M. A., Ashik, M. A. R., Zaman, N. N., Faruk, O., Hossain, M. S., Parvin, A., & Rahman, M. H. (2024). Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatment. Cancer Reports. https://doi.org/10.1002/cnr2.2009
Vancouver
Shornale Akter M, Uddin MH, Atikur Rahman S, Hossain MA, Ashik MAR, Zaman NN, et al. Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatment. Cancer Reports. 2024. doi:10.1002/cnr2.2009
BibTeX
@article{ShornaleAkter2024,
author = {Shornale Akter, Most and Uddin, Md Helal and Atikur Rahman, Sheikh and Hossain, Md Arju and Ashik, Md Ashiqur Rahman and Zaman, Nurun Nesa and Faruk, Omar and Hossain, Md Sanwar and Parvin, Anzana and Rahman, Md Habibur},
title = {Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatment},
journal = {Cancer Reports},
year = {2024},
doi = {10.1002/cnr2.2009}
}
EUVIMED